Summit Therapeutics (SMMT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : £51.65 Million

According to Summit Therapeutics 's latest financial reports the company's total liabilities are £51.65 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.

Summit Therapeutics - Total liabilities on balance sheet (from 2004 to 2020)

Total liabilities by year

Year	Total liabilities	Change
2019-01-31	£23.73 M	-71.25%
2018-01-31	£82.55 M	60.78%
2017-01-31	£51.34 M	301.63%
2016-01-31	£12.78 M	31.88%
2015-01-31	£9.69 M	132.02%
2014-01-31	£4.17 M	73.35%
2013-01-31	£2.41 M	3.02%
2012-01-31	£2.33 M	4.64%
2011-01-31	£2.23 M	-56.61%
2010-01-31	£5.15 M	-33.65%
2009-01-31	£7.76 M	-49.24%
2008-01-31	£15.3 M	141.81%
2007-01-31	£6.32 M	153.93%
2006-01-31	£2.49 M	611.58%
2005-01-31	£0.35 M

Total liabilities for similar companies or competitors

Company	Total liabilities	differencediff.	Country
Sarepta Therapeutics SRPT	£1.89 B	3,563.62%	🇺🇸 USA
Merrimack Pharmaceuticals MACK	£18.03 M	-65.08%	🇺🇸 USA
Coherus BioSciences CHRS	£0.47 B	813.22%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions